CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial
By Kate Buron When The U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System in 2014, Abbott harnessed the power of artificial intelligence (AI) coupled with telemedicine for managing patients with heart failure (HF). Expanded use of the system was the objective of a new trial initiated in 2018, but the onset of […]
The Trouble with Telehealth: How Disparities in Internet Access Affect Patients with Chronic Conditions
The many adverse implications of the COVID-19 pandemic have created challenges for providing medical care around the globe, resulting in an increasing burden of disease and worsening health outcomes. In the current environment, telehealth is an invaluable solution, yet disparities in access to the internet between populations may negatively affect its widespread implementation while also […]
Medicare COVID-19 Telemedicine Fact Sheet for Cardiologists
Requiring an urgent shift to digital medical services, the current COVID-19 outbreak has disrupted the contemporary healthcare model forcing federal agencies to temporarily amend guidelines in an effort to ease the transition to telemedicine. Regulations continue to change and insurance coverage for medical services has greatly expanded to promote the growing use of digital healthcare […]
Navigating Online Prescriptions for Cardiometabolic Patients
Faced with an overburdened hospital system and heightened demand, the current medical environment has had to swiftly adapt, implementing virtual care and with it the expansion of telemedicine across specialties. In an attempt to reduce the spread of the COVID-19 outbreak, recent changes in federal regulations and healthcare guidelines aim to make telehealth programs both […]
